520MO Safety and efficacy of nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with recurrent/metastatic cervical cancer (R/M Cx Ca) in checkmate 358

Ana Oaknin, K.N. Moore, T. Meyer, J.L. González, L. Devriese, Amr Mahmoud Amin, Cristopher Lao, V. Boni, W.H. Sharfman, J.C. Park, M. Tahara, S.L. Topalian, M.E. Magallanes Maciel, A. Molina Alavez, A. Khan, C. Copigneaux, M. Lee, C. Garnett-Benson, X. Wang, R.W. Naumann